Upcoming Allied Market Research
Nitrendipine Tablets Market

Nitrendipine Tablets Market

by Application (Hypertension, Chronic stable Angina Pectoris, Prinzmetal's Variant Angina), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50516
Pages: NA
Apr 2023 | 61 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

Nitrendipine is a calcium channel blocker medication used to treat high blood pressure (hypertension) and chest pain (angina). It works by relaxing the blood vessels and slowing down the heart rate to reduce the amount of work the heart has to do, thereby lowering blood pressure. This is usually taken in tablet form and is available in both generic and brand-name formulations. It is an effective medication when taken as directed, but it is important to follow the doctor's instructions and regularly monitor blood pressure levels. This can cause side effects, and patients are advised to contact their doctor if they experience any symptoms of an allergic reaction or worsening of their condition.
The demand for effective treatments for hypertension and angina is rapidly increasing due to the growing prevalence of cardiovascular diseases. Hypertension, also known as high blood pressure, is a major risk factor for cardiovascular diseases and is a leading cause of morbidity and mortality globally. According to the World Health Organization, around 1.13 billion people globally have hypertension, and the number is expected to increase in the coming years. This increase in the prevalence of hypertension is due to various factors such as unhealthy diets, physical inactivity, and an increase in the aging population. Angina is also a growing concern, particularly in the aging population. It is a chest pain or discomfort that occurs when the heart does not receive enough oxygen-rich blood. The increasing number of people with lifestyle-related illnesses and the growing aging population is contributing to the growth of the market. 
In view of these growing concerns, there is a significant demand for effective treatments for hypertension and angina. Nitrendipine, a calcium channel blocker, is one of the commonly prescribed medications for the treatment of hypertension and angina. This is an effective treatment option for hypertension as it helps to reduce blood pressure by relaxing the blood vessels, thereby improving blood flow and reducing the workload on the heart. It is also an effective treatment option for angina, as it helps to improve blood flow to the heart, reducing the frequency and severity of angina attacks.
Moreover, technological advancements in the production of nitrendipine tablets have played a significant role in the market's growth. These advancements have made the manufacturing process more efficient and cost-effective. They have also made it possible to produce higher-quality nitrendipine tablets with consistent composition, potency, and effectiveness.
The use of automated production systems is one of the key technological advancements in the production of nitrendipine tablets. These systems automate many of the manual processes involved in the production of nitrendipine tablets, lowering the risk of errors and increasing overall production efficiency. Automated systems also give manufacturers more control over the manufacturing process, allowing them to produce nitrendipine tablets of consistent quality and potency.
The use of continuous manufacturing processes is another significant technological advancement. Continuous manufacturing processes are gaining popularity in the pharmaceutical industry due to several advantages they offer over traditional batch-based manufacturing processes. Continuous manufacturing processes allow for the continuous and uninterrupted production of nitrendipine tablets, reducing production time and improving process efficiency.
New product launches to flourish in the market
Pfizer's "Nitol" Nitrendipine Tablets: Pfizer launched "Nitol" in 2022, a new product in the nitrendipine tablet market, which has received positive reviews from healthcare professionals for its effectiveness in managing hypertension. Also, Novartis' "Nirvas" Nitrendipine Tablets: Novartis launched "Nirvas" in 2022, which is a once-daily dose nitrendipine tablet that has been well-received in the market for its convenience and efficacy. Moreover, GlaxoSmithKline's "Niramol" Nitrendipine Tablets: GlaxoSmithKline launched "Niramol" in 2022, which is a new nitrendipine tablet that offers a sustained-release formulation for the management of hypertension. Similarly, Merck's "Nitrin" Nitrendipine Tablets: Merck introduced "Nitrin" in 2022, which is a new nitrendipine tablet with an improved pharmacokinetic profile and better bioavailability, making it a popular choice for the treatment of hypertension.
Segment Overview: 
By application: The nitrendipine tablets market is divided into hypertension, chronic stable angina pectoris, and prinzmetal's variant angina. Nitrendipine tablets are used in the management of hypertension to lower high blood pressure. In the treatment of chronic stable angina pectoris, nitrendipine is used to reduce chest pain by increasing the supply of oxygen to the heart. And for Prinzmetal's variant angina, nitrendipine is used to prevent sudden, severe chest pain caused by a temporary reduction in blood flow to the heart.
By distribution channel: The nitrendipine tablets market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Nitrendipine tablets are readily available in retail pharmacies, where patients can purchase the medication without a prescription. In hospital settings, nitrendipine tablets are usually dispensed by a hospital pharmacy to patients admitted for treatment. Nitrendipine tablets can also be purchased online through various online pharmacies, which offer the convenience of ordering from the comfort of one's home. However, it is important to note that prescription medications like nitrendipine should only be purchased from trusted and licensed online pharmacies to avoid counterfeit or expired medications. 
By region: The Asia-Pacific nitrendipine tablet market is expected to grow at a high CAGR due to various factors such as increasing incidence of hypertension, rising geriatric population, and growing awareness about hypertension management. Hypertension is a growing concern in the Asia-Pacific region, particularly in countries such as China, India, and Japan, where lifestyle changes and stress levels have led to a rise in hypertension cases. As a result, there is a growing demand for effective hypertension management, which is fuelling the growth of the nitrendipine tablet market in the region.
There is also a growing awareness of hypertension and its management in the Asia-Pacific region. Governments, health organizations, and pharmaceutical companies are investing in public education campaigns to raise awareness about hypertension and its treatment options. This is leading to an increased demand for nitrendipine tablets, as patients become more informed about the benefits of using nitrendipine for the management of hypertension. In addition, the growing healthcare infrastructure and increasing access to healthcare services in the Asia-Pacific region are also contributing to the growth of the nitrendipine tablet market. With growing disposable incomes and the availability of health insurance, patients are more likely to seek medical treatment for hypertension, which is driving the demand for nitrendipine tablets.
Competitive analysis and profiles of the major players in the nitrendipine tablets market, such as Actavis, Anant Pharmaceuticals Pvt. Ltd., Bayer AG, Boai Pharmaceutical, DTPHARM, Liye Pharmaceutical, Nanjing Pharmaceutical Factory, Teva Pharmaceutical Industries Ltd, and Xiyue Pharmaceutical. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the nitrendipine tablets market. 

Nitrendipine Tablets Market Report Highlights

Aspects Details
By Application
  • Hypertension
  • Chronic stable Angina Pectoris
  • Prinzmetal's Variant Angina
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Nanjing Pharmaceutical Factory, Xiyue Pharmaceutical, DTPHARM, Boai Pharmaceutical, Actavis, Liye Pharmaceutical, Teva Pharmaceutical Industries Limited, anant pharmaceuticals pvt. ltd., Bayer AG

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Nitrendipine Tablets Market

Start reading.
This Report and over 19,981+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,600
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers